Director, Rare Disease KOL Marketing & Speaker Strategy

Ipsen Biopharmaceuticals Inc.; Cambridge (MA); On-site; USD 180,000 - 240,000; Full time

Job summary

Ipsen Biopharmaceuticals Inc. in Cambridge, MA seeks a Director of Key Opinion Leader Marketing for Rare Disease to lead external expert engagement and peer-to-peer education across the portfolio.

You will drive branded education initiatives, align with launch plans, and influence senior stakeholders with data-driven insights. The role requires deep expertise in KOL engagement, speaker programs, and congress strategy, partnering with Medical, Regulatory, Legal, and Ethics to ensure compliant

Qualifications

• 12+ years in commercial pharma with US peer-to-peer or HCP marketing in rare disease.
• Proven track record managing speaker bureaus and KOL programs.
• Experience planning local, regional, and national congresses.

Responsibilities

• Own and evolve the peer-to-peer engagement strategy across the US Rare Disease portfolio.
• Establish portfolio-level KOL, speaker, and advocate engagement frameworks and investment priorities.
• Lead congress roadmap, capabilities, and related processes to maximize impact.
• Ensure a cohesive peer-to-peer experience aligned to brand strategy and priorities.
• Shape how peer influence is leveraged across the customer journey for awareness and adoption.
• Define governance for speaker engagement, contracting, and HCP transparency.

Skills

Peer-to-Peer Marketing

KOL Engagement

Speaker Programs

Congress Strategy

Regulatory Understanding

Job description

Ipsen Biopharmaceuticals Inc. in Cambridge, MA seeks a Director of Key Opinion Leader Marketing for Rare Disease to lead external expert engagement and peer-to-peer education across the portfolio.

You will drive branded education initiatives, align with launch plans, and influence senior stakeholders with data-driven insights. The role requires deep expertise in KOL engagement, speaker programs, and congress strategy, partnering with Medical, Regulatory, Legal, and Ethics to ensure compliant